rpsL gene analysis associated with streptomycin resistance in Mycobacterium tuberculosis

Acta Genetica Sinica

Volumn 30, Issue 4, 2003, Pages 376-381

  Huang, Hai Nan ^a   Han, Jin Xiang ^a   Wang, Jin Hong ^b   Song, Chang Zheng ^a   Liang, Hao ^a   Zhang, Zhong Ling ^a  

^a Shandong Medicinal Biotechnology Center   (China)

^b SHANDONG PROVINCIAL CHEST HOSPITAL   (China)

Author keywords

Gene mutation; Mycobacterium tuberculosis; RspL gene; Streptomycin

Indexed keywords

STREPTOMYCIN;

ACCURACY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; GENE MUTATION; GENETIC ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

BASE SEQUENCE; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA MUTATIONAL ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; MOLECULAR SEQUENCE DATA; MUTATION; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RIBOSOMAL PROTEINS; SEQUENCE HOMOLOGY, NUCLEIC ACID; STREPTOMYCIN;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0037399171     PISSN: 03794172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon S V, Eiglmeier K, Gas S, Barry C E 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Barrell B G. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature, 1998, 11; 393(6685): 537-544.
2. Cole S T, Barrell B G. Analysis of the genome of Mycobacterium tuberculosis H37Rv. Novartis Found Symp, 1998, 217: 160-172; discussion 172-177.
3. Ruiz P, Rodriguez-Cano F, Zerolo F J, Casal M. Casal M. Investigation of the in vitro activity of streptomycin against Mycobacterium tuberculosis. Microb Drug Resist, 2002, 8(2): 147-149.
4. Ramaswamy S, Musser J M. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update, Tuber Lung Dis, 1998, 79(1): 3-29.
5. Busse H J, Wostmann C, Bakker E P. The bactericidal action of streptomycin: membrane permeabilization caused by the insertion of mistranslated proteins into the cytoplasmic membrane of Escherichia coli and subsequent caging of the antibiotic inside the cells due to degradation of these proteins. J Gen Microbiol, 1992, 138: 551-561.
6. Dobner P, Bretzel G, Rusch-Gerdes S, Feldmann K, Rifai M, Loscher T, Rinder H. Geographic variation of the predictive values of genomic mutations associated with streptomycin resistance in Mycobacterium tuberculosis. Mol Cell Probes, 1997, 11(2): 123-126.
7. Ohno H, Koga H, Kohno S. Multidrug-resistant tuberculosis. 2. Mechanisms of drug-resistance in Mycobacterium tuberculosis - genetic mechanisms of drug-resistance. Kekkaku, 1998, 73(11): 657-663.
8. Mieskes K T, Rusch-Gerdes S, Truffot-Pernot C, Feldmann K, Tortoli E, Casal M, Loscher T, Rinder H. Rapid, simple, and culture-independent detection of rpsL codon 43 mutations that are highly predictive of streptomycin resistance in Mycobacterium tuberculosis. Am J Trop Med Hyg, 2000, 63(1-2): 56-60.
9. The Chinese antituberculosis association bacteriological detective rules of tuberculosis. The Journal of the Chinese antituberculosis association, 1996, 18(2): 80-85.
10. Eisenach K D, Cave M D, Bates J H, Crawford J T. Polymerase chain reaction amplification of a repetitive DNA sequence specific for Mycobacterium tuberculosis. J Infect Dis, 1990, 161(5): 977-981.
11. WU Xue-Qiong, ZHUANG Yu-Hui, ZHANG Jun-Xian. Analysing the biological mechanisms of drug-resistance of Mycobacterium tuberculosis by moleculer biological shills. ACTA of 309 hospital, 1997, 7(3): 1-8.
12. Sharma M, Altamirano M, Prasad H K, Myneedo V P, Nand N. Charracterization by single strand conformation polymorphism of mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis in strains from Vancouver, Mexico City and New Delhi. J Assoc Physicians India, 2000, 48(6): 568-572.
13. Bobadilla-del-Valle M, Ponce-de-Leon A, Arenas-Huertero C, Vargas-Alarcon G, Kato-Maeda M, Small PM, Couary P, Ruiz-Palacios G M, Sifuentes-Osornio J. rpoB Gene mutations in rifampin-resistant Mycobacterium tuberculosis identified by polymerase chain reaction singlestranded conformational polymorphism. Emerg Infect Dis, 2001, 7(6): 1010-1013.
14. Portugal I, Covas M J, Brum L, Viveiros M, Ferrinho P, Moniz-Pereira J, David H. Outbreak of multiple drug-resistant tuberculosis in Lisbon: detection by restriction fragment length polymorphism analysis. Int J Tuberc Lung Dis, 1999, 3(3): 207-213.
15. Gomez Marin J E, Rigouts L, Villegas Londono L E, Portaels F. Restriction fragment length polymorphism (RFLP) analysis and tuberculosis epidemiology. Bull Pan Am Health Organ, 1995, 29(3): 226-236.
16. www.ncbi.nlm.nih.gov/cgi-bin/Entrez/genom_table_cgi
17. Altschul S F, Gish W, Miller W, Myers E W, Lipman D J. Basic local alignment search tool. J Mol Biol, 1990, 215(3): 403-410.
18. Alcaide F, Telenti A. Molecular techniques in the diagnosis of drugresistant tuberculosis. Ann Acad Med Singapore, 1997, 26(5): 647-650.
19. Taniguchi H. Molecular mechanisms of multidrug resistance in Mycobacterium tuberculosis. J UOEH, 2000, 22(3): 269-282.
20. Kamholz S L. Drug resistant tuberculosis. J Assoc Acad Minor Phys, 2002, 13(2): 53-56.
21. Riska P F, Jacobs W R Jr, Alland D. Molecular determinants of drug resistance in tuberculosis. Int J Tuberc Lung Dis, 2000, 4(2 suppl 1): S4-10.
22. Nachamkin I, Kang C, Weinstein M P. Detection of resistance to isoniazid, rifampin, and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods. Clin Infect Dis, 1997, 24(5): 894-900.
23. Rattan A, Kalia A, Ahmad N. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. Emerg Infect Dis, 1998, 4(2): 195-209.
24. Leitritz L, Schubert S, Bucherl B. Evaluation of BACTEC MGIT 960 and BACTEC460TB systems for recovery of mycobacteria from clinical specimens of a university hospital with low incidence of tuberculosis. J Clin Microbiol, 2001, 39(10): 3764-3767.
25. Tortoli E, Benedetti M, Fontanelli A, Simonetti M T. Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC460TB method and the agar plate method of proportion. J Clin Microbiol, 2002, 40(2): 607-610.